cro.directory
← Compare landing

GemPharmatech vs LIDE Biotech

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryGemPharmatechLIDE Biotech
SummaryGemPharmatech develops and supplies genetically engineered mouse models (GEMMs) and preclinical research services using CRISPR/Cas9 and gene-editing technologies, with a library of 25,000+ mouse strains including KO/cKO, humanized, and immunodeficient models.Oncology-focused preclinical CRO with AAALAC-accredited China-based labs offering 2300+ PDX models, MiniPDX organoid assays, and multi-omics analysis for drug discovery and development.
Services
  • Target Identification & Validation
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • Specialized & Large-Animal Models
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • Specialized & Large-Animal Models
  • Biomarker Assays
  • Immunology & Inflammation Services
  • Oncology Specialty Services
  • Genomics & Sequencing Services
  • Proteomics Services
Modalities
  • Biologics (Monoclonal Antibodies)
  • Antibody-Drug Conjugate (ADC)
  • Cell Therapy
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Rare Disease
  • Oncology
  • Immunology
Phases
  • Preclinical (General)
  • Preclinical (IND-Enabling)
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
Sourcing models
  • Full-Service Outsourcing (FSO)
  • Full-Service Outsourcing (FSO)
Locations
  • Headquarters, Jiangsu, China
  • Headquarters, China
CertificationsData not yet provided.
  • AAALAC · Identifier: AAALAC accredited

Find similar companies

GemPharmatech alternatives · LIDE Biotech alternatives

Markdown mirror: /compare/gempharmatech/lide-biotech.md